Personalized Immune Cell Treatment NKCL Classic
NKCL Bio Group is opening 'NK Immune Cafes' which combine the company's immune care platform with non-face-to-face unmanned cafe. As the number of daily confirmed cases hit 1000, all activities are subject to greater social and economic constraints. But NKCL Bio Group is taking advantage of the situa...
NKCL Bio Group has won the grand prize in the technology innovation category of immune cell cultivation in the 8th Best Future Creative Management Awards 2020 organized by Money Today. NKCL Bio Group (Chairman Shin Dong-hwa) is a bio company that researches and develops immune cell therapy using NK i...
The daily number of newly confirmed COVID-19 patients surpassed the 500 mark for the first time in eight months since the outbreak of the pandemic in early March. Now is a time when immunity management is more important than ever. This is why NK Immune Cafe, which seeks to establish an immunity boost...
NKCL Bio Group is the first in the bio industry to open a course for immunity enhancement at Songwon University's Lifelong Education Center in Gwangju. The course teaches about NK immune cells and their cultivation technology. The immunity enhancement counselor training course is taught by Chairman S...
NKCL Bio Group, as the first in its industry, to open a course regarding NK Immune Cell and its cultivation, under the curriculum provided by Songwon University, Kwang-ju, Korea. As the Advanced Regenerative Medicine Act passed the bill, the interest is growing in bio-industry, especially NK Immune C...
The interest in health and immunity is higher than ever, and the demand for a premium water grew as well. NKCL Bio group has launched a premium deep ocean drinking water rich in minerals. NKCL’s ‘NK Immune Water’ comes in two sizes; 500 ml and 350 ml. They can be easily consumed with NKCL’s powde...
“We will build up Personalized-Immune Care Platform by enhancing people’s health using NK immune cell, as well as various products and programs.” said Shin Dong-Hwa the chairman of NKCL Bio Group. NKCL Bio Group researches and develops immune cell therapy using NK immune cells based on its excelle...
NKCL Bio Group Inc. has signed MOA on April 27 with Qingdao Orthopedic Hospital (颐生健骨伤医院) , a hospital affiliated with China-TSRH Association in China, for business cooperation. In line with the social distancing, the MOA signing was held in the form of real-time video conference, and the numb...
NKCL Bio Group, a Korean bio-company that research and develops immune cell therapy, is attracting attention as a beneficiary company of ‘the Act on the Safety and Support of Advanced Regenerative Medicine and Advanced Bio-Pharmaceuticals' (hereinafter referred to as the Advanced Medicine Act). The ...
The Ministry of Food and Drug Safety and the Ministry of Health and Welfare announced on the 25th that the enactment of the Enforcement Decree of ‘The Act on the Safety and Support of Advanced Regenerative Medicine and Advanced Biopharmaceuticals' has passed the cabinet meeting. The Advanced Regener...
